• Skip to main content
  • Skip to primary sidebar
  • Home
  • News
  • Education
  • Events
  • Interviews
    • Career spotlight
  • Opinion
    • Professional Dilemmas
    • Patient perspective
  • PIPcast
  • Jobs
  • Business Directory

Pharmacy in Practice

EDX/20/1154
Date of prep: December 2020

Prescribing information and
adverse events reporting

For healthcare professionals only

📺 On demand webinar: Anna Murphy: Respiratory clinical pearls

7th December 2020 by PIP editor Leave a Comment

 

Professor Anna Murphy has for many years now demonstrated the highest level of leadership in pharmacy in the respiratory field. Anna is a Consultant Pharmacist with an interest in respiratory medicine and is widely published in this area. She has a passion for teaching professionals and patients about all things respiratory.

 

We were therefore very proud to welcome Anna to share her respiratory clinical pearls gleaned from the vast experience she has gained in her impressive career.

 

This is the first of two learning activities. We also recorded a question and answer session with Anna.

 

This webinar was been supported by Orion Pharma (UK) Ltd. They have had no input into any aspect of the design and, or delivery of the advertised webinar.

 

Orion Pharma (UK) Ltd is a subsidiary of Orion Corporation, a pharmaceutical company based in Finland. Orion Pharma (UK) Ltd carries out extensive research with a goal of introducing new treatments into global markets. Core therapy areas in Orion’s product and research strategy are Respiratory, Central Nervous System (CNS), Oncology and Critical Care. Visit www.orionpharma.co.uk.

 

Click here to access the on-demand content

 

About Professor Anna Murphy

 

Anna Murphy is a consultant respiratory pharmacist at University Hospitals of Leicester NHS Trust and honorary visiting professor at DeMontfort University. The clinical aspect of her post offers assessment, medicines optimisation, monitoring and advice to people with respiratory disease, working both in hospital and across the interface. Anna currently works with several national groups and organisations on issues surrounding prescribing in respiratory disease. Anna has published widely and produced the “7-Steps to Success” education materials. Research interests include medicine adherence in people with respiratory disease and pharmacy practice research.

 

If you would like to be kept informed about future live events being run by Pharmacy in Practice simply fill in the form below to give us permission to contact you appropriately. 

 

Go to pip.scot to read our privacy policy.

 

 

 

Related

Filed Under: Education, On demand Tagged With: On demand, webinar

Register for our upcoming webinar and live Q&A

About PIP editor

Pharmacy in Practice is a UK pharmacy publication with its roots in Scotland.

Reader Interactions

Begin the discussion right here Cancel reply

Primary Sidebar

Categories

PIP business directory

Letters to the editor

Letters to the editor

Pharmacists severely limited without patient record access

‘PRN’ medicines like Tramadol should never be on repeat

The ‘ART’ of Scottish community pharmacy is all about data

Should pharmacists be sent to check home medicine cupboards?

More letters to the editor here...

Blogs

💊 PIP live pharmacy blog

Winter stresses must not ‘destabilise’ general practice

What is it like to depend on medicine to treat endometriosis?

Opinion

Why is pharmacy not integral to government mass vaccination plans?

Pharmacy Covid-19 vaccination involvement is a ‘no-brainer’

The great patient medication returns debacle

CPD Challenges

💊 CPD Challenge: How well do you understand pulmonary embolisms?

💊 CPD Challenge: Prescribing and dispensing clozapine

💊 CPD Challenge: Oral anticoagulants – Dabigatran

More CPD challenges here...

© 2021 · About Pharmacy In Practice · Site mantained by Mike

This site is for healthcare professionals, please confirm you are a healthcare professional to continue.

YES

Pharmacy In Practice uses cookies, by continuing to use this site we will assume you are ok with that Find out more.